IL328729A - שיטות לייצור תאים דמויי איים שמקורם בתאי גזע, כמו גם אוכלוסיות והרכבים הכוללים אותם - Google Patents

שיטות לייצור תאים דמויי איים שמקורם בתאי גזע, כמו גם אוכלוסיות והרכבים הכוללים אותם

Info

Publication number
IL328729A
IL328729A IL328729A IL32872926A IL328729A IL 328729 A IL328729 A IL 328729A IL 328729 A IL328729 A IL 328729A IL 32872926 A IL32872926 A IL 32872926A IL 328729 A IL328729 A IL 328729A
Authority
IL
Israel
Prior art keywords
populations
cells
methods
well
stem cell
Prior art date
Application number
IL328729A
Other languages
English (en)
Inventor
Hozefa Bandukwala
Alexander Efanov
Christine Ivashchenko
Enxuan Jing
Ying Jing
Olivia Kelly
Matthew T Lambalot
Tristan Fabian Samuel Lawson
Jr Penn Mason Mcclatchey
Nicholas Joseph Mozdzierz
Xiaoying Shi
Melissa Thomas
Original Assignee
Sigilon Therapeutics Inc
Hozefa Bandukwala
Alexander Efanov
Christine Ivashchenko
Enxuan Jing
Ying Jing
Olivia Kelly
Matthew T Lambalot
Tristan Fabian Samuel Lawson
Jr Penn Mason Mcclatchey
Nicholas Joseph Mozdzierz
Xiaoying Shi
Melissa Thomas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigilon Therapeutics Inc, Hozefa Bandukwala, Alexander Efanov, Christine Ivashchenko, Enxuan Jing, Ying Jing, Olivia Kelly, Matthew T Lambalot, Tristan Fabian Samuel Lawson, Jr Penn Mason Mcclatchey, Nicholas Joseph Mozdzierz, Xiaoying Shi, Melissa Thomas filed Critical Sigilon Therapeutics Inc
Publication of IL328729A publication Critical patent/IL328729A/he

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C12N5/0678—Stem cells; Progenitor cells; Precursor cells

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL328729A 2023-12-01 2024-11-21 שיטות לייצור תאים דמויי איים שמקורם בתאי גזע, כמו גם אוכלוסיות והרכבים הכוללים אותם IL328729A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363605259P 2023-12-01 2023-12-01
PCT/US2024/056908 WO2025117331A1 (en) 2023-12-01 2024-11-21 Methods of making stem cell-derived islet-like cells, as well as populations and compositions including the same

Publications (1)

Publication Number Publication Date
IL328729A true IL328729A (he) 2026-07-01

Family

ID=93853415

Family Applications (1)

Application Number Title Priority Date Filing Date
IL328729A IL328729A (he) 2023-12-01 2024-11-21 שיטות לייצור תאים דמויי איים שמקורם בתאי גזע, כמו גם אוכלוסיות והרכבים הכוללים אותם

Country Status (5)

Country Link
AU (1) AU2024391032A1 (he)
DO (1) DOP2026000157A (he)
IL (1) IL328729A (he)
TW (1) TW202540402A (he)
WO (1) WO2025117331A1 (he)

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4391909A (en) 1979-03-28 1983-07-05 Damon Corporation Microcapsules containing viable tissue cells
US4378016A (en) 1981-07-15 1983-03-29 Biotek, Inc. Artificial endocrine gland containing hormone-producing cells
JPH11508477A (ja) 1996-02-23 1999-07-27 サーシ・バイオメディカル・インコーポレーテッド 新規の人工膵臓
US5647289A (en) 1996-05-06 1997-07-15 The Needle Doctor, Inc. Perimeter sewing system
JP2001508302A (ja) 1997-01-10 2001-06-26 ライフ テクノロジーズ,インコーポレイテッド 胚性幹細胞血清置換
US6326201B1 (en) 1999-02-10 2001-12-04 Curis, Inc. Pancreatic progenitor cells, methods and uses related thereto
GB2399823B (en) 2001-12-07 2006-02-15 Geron Corp Islet cells from primate pluripotent stem cells
EP1539930A4 (en) * 2002-07-29 2006-08-09 Es Cell Int Pte Ltd METHOD IN MULTIPLE STAGES OF DIFFERENTIATION OF POSITIVE INSULIN-SENSITIVE CELLS, GLUCOSE
US20090227032A1 (en) 2005-12-13 2009-09-10 Kyoto University Nuclear reprogramming factor and induced pluripotent stem cells
US8278104B2 (en) 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
EP2206724A1 (en) 2005-12-13 2010-07-14 Kyoto University Nuclear reprogramming factor
US20090298169A1 (en) 2006-06-02 2009-12-03 The University Of Georgia Research Foundation Pancreatic and Liver Endoderm Cells and Tissue by Differentiation of Definitive Endoderm Cells Obtained from Human Embryonic Stems
WO2007149328A1 (en) 2006-06-20 2007-12-27 Genzyme Corporation Serum-free media and their uses for chondrocyte expansion
JP2008307007A (ja) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
US9683232B2 (en) 2007-12-10 2017-06-20 Kyoto University Efficient method for nuclear reprogramming
WO2012112982A2 (en) 2011-02-18 2012-08-23 Massachusetts Institute Of Technology Hydrogel encapsulated cells and anti-inflammatory drugs
CA2837558C (en) 2011-06-02 2018-11-20 Massachusetts Institute Of Technology Modified alginates for cell encapsulation and cell therapy
RU2705001C2 (ru) 2011-12-22 2019-11-01 Янссен Байотек, Инк. Дифференцировка эмбриональных стволовых клеток человека в одногормональные инсулинположительные клетки
RU2015100900A (ru) 2012-06-14 2016-08-10 Янссен Байотек, Инк. Обработка плюрипотентных клеток
KR102084561B1 (ko) 2012-12-31 2020-03-04 얀센 바이오테크 인코포레이티드 췌장 내분비 세포로의 분화를 위한 공기-액체 계면에서의 인간 배아 줄기세포의 배양
WO2014130887A1 (en) 2013-02-22 2014-08-28 Cedars-Sinai Medical Center Pancreatic insulin-producing beta-cell lines derived from human pluripotent stem cells
US20140287944A1 (en) 2013-02-26 2014-09-25 President And Fellows Of Harvard College Markers for functionally mature beta-cells and methods of using the same
US8859286B2 (en) 2013-03-14 2014-10-14 Viacyte, Inc. In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells
US9555007B2 (en) 2013-03-14 2017-01-31 Massachusetts Institute Of Technology Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates
US10172791B2 (en) 2013-03-14 2019-01-08 Massachusetts Institute Of Technology Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates
WO2015013653A1 (en) 2013-07-26 2015-01-29 The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone Generating definitive endoderm and pancreatic progenitor cells
DK3039122T3 (da) 2013-08-30 2019-09-30 Novo Nordisk As Generering af endokrine progenitorceller fra humane pluripotente stamceller under anvendelse af små molekyler
ES3036749T3 (en) 2014-08-01 2025-09-23 Massachusetts Inst Technology Modified alginates for anti-fibrotic materials and applications
CN107614678B (zh) 2014-12-18 2021-04-30 哈佛学院校长同事会 干细胞来源的β细胞的产生方法及其使用方法
CN107250349A (zh) * 2014-12-19 2017-10-13 詹森生物科技公司 多能干细胞的悬浮培养
US10975355B2 (en) 2015-04-23 2021-04-13 The Regents Of The University Of California Controlled induction of human pancreatic progenitors produces functional beta-like cells
PT3285572T (pt) 2015-04-24 2021-03-04 Univ Copenhagen Método para a produção de células produtoras de insulina
JP2018521717A (ja) 2015-05-17 2018-08-09 マサチューセッツ インスティテュート オブ テクノロジー 細胞および細胞凝集体を封入するための多層ヒドロゲルカプセル
US11332716B2 (en) 2015-07-27 2022-05-17 The Regents Of The University Of California Methods and compositions for producing pancreatic beta cells
CA3003738C (en) 2015-11-01 2021-01-12 Massachusetts Institute Of Technology Materials with improved properties
ES2978718T3 (es) 2015-11-01 2024-09-18 Massachusetts Inst Technology Alginatos modificados para materiales antifibróticos y aplicaciones
MA45329A (fr) 2016-04-08 2019-02-13 Univ California Production de cellules bêta matures pleinement fonctionnelles à partir de progénitrices pancréatiques humaines
CA3027200A1 (en) 2016-06-13 2017-12-21 Massachusetts Institute Of Technology Biocompatible zwitterionic polymer coatings and hydrogels for reducing foreign body response and fibrosis
CA3027879A1 (en) 2016-06-21 2017-12-28 Janssen Biotech, Inc. Generation of human pluripotent stem cell derived functional beta cells showing a glucose-dependent mitochondrial respiration and two-phase insulin secretion response
KR20230156818A (ko) 2016-10-03 2023-11-14 시질론 테라퓨틱스, 인크. 화합물, 장치, 및 이의 용도
WO2018089928A1 (en) 2016-11-11 2018-05-17 Whitehead Institute For Biomedical Research Human plasma-like medium
EP3538673B1 (en) 2016-11-11 2026-05-20 University of Pittsburgh- Of the Commonwealth System of Higher Education IDENTIFICATION OF SPECIFIC SOMATIC GENOME ALTERATIONS IN AN INSTANCE WITH A FUNCTIONAL IMPACT
IL266478B2 (he) 2016-11-16 2025-02-01 Allele Biotechnology & Pharmaceuticals Inc השראת תאי בטא לבלביים באמצעות התמיינות תאי גזע עם רנ" א
WO2018119155A1 (en) 2016-12-20 2018-06-28 The Regents Of The University Of California Methods of pancreatic differentiation of stem cells
NL2019204B1 (en) 2017-07-07 2019-01-16 Atum Holding B V Apparatus to create objects and semi-rigid substrate therefor
JP2020527956A (ja) 2017-07-21 2020-09-17 センマ・セラピューティクス・インコーポレーテッド 幹細胞由来の膵臓ベータ細胞の再凝集
SG11202001906PA (en) 2017-09-11 2020-04-29 Novo Nordisk As Enrichment of nkx6.1 and c-peptide co-expressing cells derived in vitro from stem cells
WO2019099725A1 (en) 2017-11-15 2019-05-23 Semma Therapeutics, Inc. Islet cell manufacturing compositions and methods of use
WO2019169351A1 (en) 2018-03-02 2019-09-06 Semma Therapeutics, Inc. Methods of enhancing stem cell differentiation into beta cells
CN112203646A (zh) 2018-04-04 2021-01-08 西吉隆医疗股份有限公司 可植入颗粒和相关方法
WO2019208788A1 (ja) 2018-04-27 2019-10-31 株式会社カネカ 膵臓β細胞の製造方法
WO2019227198A1 (en) 2018-05-31 2019-12-05 University Health Network (Uhn) Methods and compositions comprising tankyrase inhibitors for generating insulin producing cells
EP3833365A4 (en) 2018-08-10 2022-05-11 Vertex Pharmaceuticals Incorporated Stem cell derived islet differentiation
UY38389A (es) 2018-09-27 2020-04-30 Sigilon Therapeutics Inc Dispositivos implantables para terapia celular y métodos relacionados
WO2020247954A1 (en) 2019-06-06 2020-12-10 President And Fellows Of Harvard College Compositions and methods for maturing stem cell-derived beta cells
WO2020264072A1 (en) 2019-06-25 2020-12-30 Semma Therapeutics, Inc. Enhanced differentiation of beta cells
EP4007596A1 (en) 2019-08-01 2022-06-08 Sana Biotechnology, Inc. Dux4 expressing cells and uses thereof
JP7728747B2 (ja) 2019-08-23 2025-08-25 サナ バイオテクノロジー,インコーポレイテッド Cd24発現細胞およびそれらの用途
CA3163491A1 (en) 2019-12-13 2021-06-17 Sigilon Therapeutics, Inc. Compounds, polymers, devices, and uses thereof
JP7853210B2 (ja) 2020-01-13 2026-04-28 サナ バイオテクノロジー,インコーポレイテッド 血液型抗原の修飾
EP4090747A1 (en) 2020-01-17 2022-11-23 Sana Biotechnology, Inc. Safety switches for regulation of gene expression
EP4125961A1 (en) 2020-03-25 2023-02-08 Sana Biotechnology, Inc. Hypoimmunogenic neural cells for the treatment of neurological disorders and conditions
IL297636A (he) 2020-04-27 2022-12-01 Sana Biotechnology Inc מינון חוזר של תאים היפואימונוגנים
JP7705448B2 (ja) 2020-07-31 2025-07-09 バーテックス ファーマシューティカルズ インコーポレイテッド 膵内分泌細胞の分化
CA3190778A1 (en) 2020-08-04 2022-02-10 Sigilon Therapeutics, Inc. Heteroaryl and heterocyclyl compounds
AU2021325941A1 (en) 2020-08-13 2023-03-09 Sana Biotechnology, Inc. Methods of treating sensitized patients with hypoimmunogenic cells, and associated methods and compositions
US11767504B2 (en) 2020-08-14 2023-09-26 Albcura Corporation Albumin compositions and methods of producing and using same
IL301972A (he) 2020-10-09 2023-06-01 Sana Biotechnology Inc שיטות להפעלת מנגנוני הרג בטיחותיים באמצעות גורם חסימת CD47–SIRPα
CN112980771B (zh) 2021-03-05 2023-12-19 贝康医学科技有限公司 一种制备胰腺beta细胞的方法及其应用
WO2022204377A1 (en) 2021-03-24 2022-09-29 Salk Institute For Biological Studies NOVEL CHEMICAL COMBINATIONS AND METHODS OF USE THEREOF, TOWARDS DIFFERENTIATION OF HUMAN PROGENITOR CELLS INTO FUNCTIONAL β CELLS
CA3236375A1 (en) 2021-10-28 2023-05-04 Lorenz Studer Compositions and methods for promoting in vitro maturation of cells
JP2024542041A (ja) 2021-11-01 2024-11-13 バーテックス ファーマシューティカルズ インコーポレイテッド 幹細胞由来の膵臓島分化
CA3246902A1 (en) 2022-01-10 2023-07-13 Sana Biotechnology, Inc. DIFFERENTIATED HYPOIMMUNOUS BETA CELLS FROM PURIPOTENTIC STEM CELLS AND RELATED USES AND METHODS

Also Published As

Publication number Publication date
WO2025117331A1 (en) 2025-06-05
DOP2026000157A (es) 2026-07-15
TW202540402A (zh) 2025-10-16
AU2024391032A1 (en) 2026-06-25